ArticleMolecular therapy. Oncology2026

Target choice and exon skipping regulate CRISPR-directed gene editing of NRF2 in head/neck and esophageal cancer cells.

Natalia Rivera-Torres et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.